Index S&P 500
P/E 18.37
EPS (ttm) 4.10
Insider Own 0.20%
Shs Outstand 505.11M
Perf Week -2.22%
Market Cap 37.53B
Forward P/E 16.13
EPS next Y 4.67
Insider Trans -0.79%
Shs Float 497.00M
Perf Month -1.55%
Income 2.08B
PEG 2.21
EPS next Q 1.38
Inst Own 84.62%
Short Float 1.38%
Perf Quarter -7.51%
Sales 78.02B
P/S 0.48
EPS this Y 7.15%
Inst Trans -1.10%
Short Ratio 2.48
Perf Half Y 14.79%
Book/sh 4.21
P/B 17.90
EPS next Y 8.77%
ROA 8.76%
Short Interest 6.86M
Perf Year 0.05%
Cash/sh 1.20
P/C 62.72
EPS next 5Y 8.30%
ROE 113.00%
52W Range 62.24 - 82.89
Perf YTD 3.05%
Dividend Est. 2.02 (2.69%)
P/FCF 19.09
EPS past 5Y 5.16%
ROI 13.84%
52W High -9.08%
Beta 1.18
Dividend TTM 2.00 (2.65%)
Quick Ratio 0.77
Sales past 5Y 6.47%
Gross Margin 18.38%
52W Low 21.09%
ATR (14) 1.30
Dividend Ex-Date Jul 05, 2024
Current Ratio 1.34
EPS Y/Y TTM 35.46%
Oper. Margin 4.28%
RSI (14) 42.69
Volatility 2.07% 1.51%
Employees 72000
Debt/Eq 6.24
Sales Y/Y TTM 3.26%
Profit Margin 2.66%
Recom 2.10
Target Price 87.00
Option/Short Yes / Yes
LT Debt/Eq 6.14
EPS Q/Q 0.42%
Payout 56.73%
Rel Volume 0.98
Prev Close 74.25
Sales Surprise -1.80%
EPS Surprise 1.03%
Sales Q/Q 2.67%
Earnings Apr 30 BMO
Avg Volume 2.77M
Price 75.36
SMA20 -1.07%
SMA50 -4.30%
SMA200 2.46%
Trades
Volume 2,709,673
Change 1.49%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-21-23 Resumed
Piper Sandler
Neutral
$73
Oct-19-23 Initiated
Deutsche Bank
Buy
$75
Mar-09-23 Resumed
BofA Securities
Buy
$90
Feb-02-23 Downgrade
Argus
Buy → Hold
Sep-23-22 Initiated
Stephens
Overweight
$90
May-26-22 Upgrade
JP Morgan
Neutral → Overweight
$98
Mar-11-22 Initiated
CL King
Neutral
Feb-22-22 Upgrade
Argus
Hold → Buy
$95
Feb-01-22 Initiated
Truist
Buy
$89
Jan-04-22 Initiated
Deutsche Bank
Hold
$82
Dec-15-21 Upgrade
Barclays
Equal Weight → Overweight
$80 → $86
Jul-29-21 Initiated
UBS
Buy
$89
Jan-25-21 Downgrade
JP Morgan
Overweight → Neutral
$76
Nov-10-20 Upgrade
BMO Capital Markets
Market Perform → Outperform
$60 → $88
Nov-04-20 Upgrade
Consumer Edge Research
Underweight → Equal Weight
Oct-16-20 Resumed
Jefferies
Buy
$74 → $77
Sep-29-20 Initiated
Morgan Stanley
Equal-Weight
$66
Sep-23-20 Initiated
Wolfe Research
Peer Perform
Sep-10-20 Upgrade
Edward Jones
Hold → Buy
Aug-06-20 Resumed
Credit Suisse
Outperform
$65
Show Previous Ratings
May-02-24 10:49AM
08:28AM
01:02AM
May-01-24 01:35PM
12:45PM
10:59AM
Loading…
10:59AM
10:55AM
08:50AM
08:00AM
03:16AM
02:17AM
01:47AM
(Thomson Reuters StreetEvents)
Apr-30-24 12:53PM
11:08AM
10:00AM
09:45AM
Loading…
09:45AM
09:32AM
09:10AM
08:58AM
08:58AM
08:45AM
08:07AM
(Associated Press Finance)
08:00AM
08:00AM
Apr-29-24 12:10PM
09:40AM
07:41AM
Apr-25-24 04:30PM
11:37AM
09:15AM
12:33PM
Loading…
Apr-24-24 12:33PM
Apr-23-24 10:01AM
Apr-22-24 08:00AM
Apr-15-24 05:53AM
05:17AM
04:25AM
03:14AM
02:50AM
Apr-09-24 08:00AM
Apr-05-24 01:44PM
Apr-03-24 07:04AM
Mar-27-24 12:12PM
Mar-22-24 04:37PM
Mar-21-24 01:47PM
Mar-19-24 08:49AM
Feb-29-24 11:30AM
06:45AM
Feb-21-24 04:30PM
09:30AM
Feb-13-24 08:55AM
Feb-06-24 08:00AM
Feb-01-24 06:39PM
10:50AM
Jan-31-24 02:32PM
09:35AM
01:29AM
(Thomson Reuters StreetEvents)
Jan-30-24 03:40PM
(Morningstar Research) +7.52%
02:59PM
02:04PM
11:36AM
09:30AM
09:16AM
09:10AM
08:43AM
08:07AM
(Associated Press Finance)
08:00AM
Jan-28-24 07:19PM
Jan-25-24 11:57AM
09:40AM
09:15AM
Jan-23-24 04:17PM
09:40AM
Jan-09-24 04:52PM
08:00AM
Jan-03-24 11:05AM
Dec-24-23 09:00AM
Dec-22-23 12:35PM
07:43AM
Dec-18-23 09:00AM
01:30AM
Dec-14-23 10:30AM
Dec-07-23 06:40AM
Dec-05-23 08:00AM
Dec-04-23 04:46PM
Nov-30-23 11:30AM
Nov-29-23 08:00AM
Nov-23-23 12:45PM
Nov-20-23 07:07AM
Nov-16-23 04:30PM
06:40AM
Nov-15-23 09:07PM
Nov-14-23 06:55PM
(The Wall Street Journal)
08:00AM
Nov-13-23 02:14PM
Nov-09-23 04:45PM
Nov-03-23 09:55AM
09:40AM
Nov-01-23 09:54AM
01:11AM
(Thomson Reuters StreetEvents)
Oct-31-23 06:06PM
Sysco Corp. engages in the selling, marketing, and distribution of food products to restaurants, healthcare and educational facilities, and lodging establishments. It operates through the following segments: U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other. The U.S. Foodservice Operations segment consists of U.S. Broadline operations, custom-cut meat and seafood companies, FreshPoint, and European Imports. The International Foodservice Operations segment includes operations outside of the United States which distribute a full line of food products and a wide variety of non-food products. The SYGMA segment represents U.S. customized distribution operations serving quick-service chain restaurant customer locations. The Other segment covers hotel supply operations. The company was founded by John F. Baugh in 1969 and is headquartered in Houston, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Jasper James Chris SVP Mar 14 '24 Sale 80.41 4,000 321,640 18,531 Mar 15 05:06 PM Russell Neil SVP, Corp. Affairs and CAO Mar 06 '24 Option Exercise 58.08 1,722 100,014 25,804 Mar 08 05:26 PM Russell Neil SVP, Corp. Affairs and CAO Mar 06 '24 Sale 80.00 1,722 137,760 24,082 Mar 08 05:26 PM Jasper James Chris SVP Dec 12 '23 Option Exercise 38.89 819 31,851 22,961 Dec 13 05:00 PM Talton Sheila Director Nov 22 '23 Sale 71.76 2,200 157,872 12,782 Nov 27 05:05 PM Russell Neil SVP, Corp. Affairs and CAO Sep 01 '23 Sale 69.88 219 15,304 25,154 Sep 06 05:20 PM
Index NDX, S&P 500
P/E 16.31
EPS (ttm) 3.33
Insider Own 0.17%
Shs Outstand 554.94M
Perf Week 0.54%
Market Cap 30.14B
Forward P/E 14.11
EPS next Y 3.84
Insider Trans 0.00%
Shs Float 554.69M
Perf Month 0.89%
Income 1.84B
PEG 2.42
EPS next Q 0.61
Inst Own 79.35%
Short Float 1.37%
Perf Quarter -9.31%
Sales 13.79B
P/S 2.19
EPS this Y 6.42%
Inst Trans 0.35%
Short Ratio 1.34
Perf Half Y -10.39%
Book/sh 32.12
P/B 1.69
EPS next Y 7.85%
ROA 2.91%
Short Interest 7.60M
Perf Year -20.80%
Cash/sh 1.06
P/C 51.35
EPS next 5Y 6.73%
ROE 10.62%
52W Range 46.79 - 69.85
Perf YTD -12.37%
Dividend Est. 2.19 (4.04%)
P/FCF -
EPS past 5Y 5.37%
ROI 4.07%
52W High -22.33%
Beta 0.39
Dividend TTM 2.11 (3.88%)
Quick Ratio 0.74
Sales past 5Y 4.67%
Gross Margin 24.47%
52W Low 15.94%
ATR (14) 1.06
Dividend Ex-Date Mar 14, 2024
Current Ratio 0.86
EPS Y/Y TTM 2.88%
Oper. Margin 19.80%
RSI (14) 52.04
Volatility 1.63% 1.74%
Employees 11311
Debt/Eq 1.60
Sales Y/Y TTM -11.69%
Profit Margin 13.35%
Recom 2.11
Target Price 62.43
Option/Short Yes / Yes
LT Debt/Eq 1.53
EPS Q/Q 15.70%
Payout 64.83%
Rel Volume 0.52
Prev Close 53.79
Sales Surprise -11.52%
EPS Surprise 13.61%
Sales Q/Q -10.39%
Earnings Apr 25 BMO
Avg Volume 5.68M
Price 54.25
SMA20 0.46%
SMA50 1.49%
SMA200 -6.84%
Trades
Volume 2,953,952
Change 0.86%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Upgrade
Wolfe Research
Peer Perform → Outperform
$58
Mar-11-24 Upgrade
Barclays
Equal Weight → Overweight
$61 → $54
Oct-06-23 Upgrade
BofA Securities
Neutral → Buy
$58 → $66
Aug-24-23 Initiated
Barclays
Equal Weight
$60
Aug-22-23 Downgrade
BofA Securities
Buy → Neutral
$72 → $60
Jun-21-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
Jun-08-23 Initiated
Goldman
Buy
$75
Jun-02-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Jun-02-23 Downgrade
JP Morgan
Overweight → Neutral
$79 → $68
Nov-21-22 Downgrade
Credit Suisse
Outperform → Neutral
$68
Oct-20-22 Upgrade
Wolfe Research
Peer Perform → Outperform
$69
Apr-26-22 Initiated
Credit Suisse
Outperform
$80
Jan-25-22 Upgrade
Evercore ISI
In-line → Outperform
$75
Jan-10-22 Upgrade
Mizuho
Neutral → Buy
$64 → $72
Nov-22-21 Upgrade
BMO Capital Markets
Market Perform → Outperform
$68 → $70
Oct-29-21 Upgrade
BofA Securities
Neutral → Buy
$67 → $72
Oct-19-21 Upgrade
Morgan Stanley
Underweight → Equal-Weight
$65
Oct-13-21 Upgrade
Goldman
Neutral → Buy
$73 → $76
Oct-01-21 Upgrade
Barclays
Equal Weight → Overweight
$75 → $76
Oct-26-20 Initiated
Citigroup
Neutral
$76
Show Previous Ratings
May-03-24 11:36AM
Apr-30-24 11:51AM
07:22AM
07:20AM
Apr-26-24 12:55PM
11:05AM
Loading…
11:05AM
11:01AM
10:51AM
01:08AM
Apr-25-24 08:59PM
02:28PM
11:33AM
10:55AM
10:40AM
09:30AM
08:24AM
Loading…
08:24AM
07:35AM
07:32AM
06:12AM
(Associated Press Finance)
06:05AM
Apr-22-24 02:50PM
09:16AM
Apr-17-24 07:30AM
Apr-15-24 03:04AM
Apr-09-24 10:16AM
Apr-08-24 02:15PM
Apr-07-24 01:09PM
Apr-01-24 03:48PM
Mar-27-24 05:20PM
Mar-21-24 07:38AM
11:18AM
Loading…
Mar-08-24 11:18AM
Mar-07-24 02:32PM
(The Wall Street Journal)
11:19AM
10:14AM
(Associated Press Finance)
09:42AM
(The Wall Street Journal)
09:22AM
09:09AM
09:00AM
Mar-01-24 06:55PM
06:42PM
06:41PM
05:00PM
12:00PM
(The Wall Street Journal)
Feb-29-24 08:01PM
(Morningstar Research) -8.64%
04:49PM
02:49PM
(The Wall Street Journal)
01:55PM
01:45PM
(The Wall Street Journal)
12:55PM
Feb-22-24 12:08AM
Feb-21-24 12:06PM
02:11AM
Feb-07-24 04:10AM
Feb-06-24 05:53PM
Feb-05-24 01:53AM
Feb-01-24 08:45AM
Jan-31-24 08:05AM
07:24AM
Jan-29-24 06:10AM
Jan-26-24 01:50AM
(Thomson Reuters StreetEvents)
Jan-25-24 12:43PM
12:20PM
11:51AM
10:13AM
09:30AM
07:48AM
07:32AM
07:20AM
06:26AM
(Associated Press Finance)
06:05AM
Jan-23-24 06:48AM
Jan-22-24 01:11PM
Jan-19-24 08:43AM
Jan-18-24 10:00AM
Jan-17-24 05:11AM
Jan-10-24 02:43PM
Jan-09-24 01:46PM
Jan-08-24 10:16AM
Jan-05-24 07:41PM
Jan-03-24 05:15PM
Dec-26-23 05:03AM
Dec-19-23 10:12PM
Dec-18-23 02:54AM
02:54AM
Dec-17-23 05:14AM
Dec-14-23 05:12PM
(Associated Press Finance)
Dec-13-23 08:35PM
04:10PM
Dec-07-23 09:12AM
01:58AM
Dec-05-23 09:24AM
08:00AM
05:04AM
Nov-30-23 03:43PM
11:48AM
Nov-22-23 06:00AM
Nov-07-23 03:19PM
Nov-03-23 04:00AM
Oct-30-23 09:10AM
Oct-28-23 12:31PM
Xcel Energy, Inc. is an electric and natural gas delivery company. It operates through the following three segments: Regulated Electric, Regulated Natural Gas Utility and All Others. The Regulated Electric segment focuses on generating, purchasing, transmitting, and distributing electricity. The Regulated Natural Gas Utility segment includes purchases, transport, stores, distribution, and sales. The All Others segment involves steam, appliance repair services, non-utility real estate activities, revenues associated with processing solid waste into refuse-derived fuel, investments in rental housing projects that qualify for low-income housing tax credits and equity method investments in energy impact partners funds. The company was founded in 1909 and is headquartered in Minneapolis, MN.
Index S&P 500
P/E -
EPS (ttm) -2.47
Insider Own 20.14%
Shs Outstand 285.23M
Perf Week 2.29%
Market Cap 21.67B
Forward P/E 17.19
EPS next Y 3.61
Insider Trans -0.22%
Shs Float 278.98M
Perf Month 4.27%
Income -857.00M
PEG -
EPS next Q 0.39
Inst Own 69.16%
Short Float 1.44%
Perf Quarter 10.04%
Sales 52.94B
P/S 0.41
EPS this Y 74.42%
Inst Trans -0.77%
Short Ratio 1.40
Perf Half Y 33.46%
Book/sh 51.95
P/B 1.19
EPS next Y 54.36%
ROA -2.33%
Short Interest 4.03M
Perf Year 2.41%
Cash/sh 4.29
P/C 14.45
EPS next 5Y 53.80%
ROE -4.54%
52W Range 44.94 - 61.71
Perf YTD 15.39%
Dividend Est. 1.95 (3.14%)
P/FCF 36.97
EPS past 5Y -
ROI -3.23%
52W High 0.50%
Beta 0.76
Dividend TTM 1.94 (3.13%)
Quick Ratio 0.67
Sales past 5Y 5.84%
Gross Margin 5.00%
52W Low 38.01%
ATR (14) 1.01
Dividend Ex-Date May 31, 2024
Current Ratio 1.49
EPS Y/Y TTM -135.67%
Oper. Margin 1.02%
RSI (14) 67.97
Volatility 1.46% 1.65%
Employees 139000
Debt/Eq 0.53
Sales Y/Y TTM -1.25%
Profit Margin -1.62%
Recom 2.60
Target Price 60.37
Option/Short Yes / Yes
LT Debt/Eq 0.46
EPS Q/Q -65.74%
Payout -
Rel Volume 1.34
Prev Close 60.95
Sales Surprise -0.14%
EPS Surprise 66.95%
Sales Q/Q 0.44%
Earnings May 06 BMO
Avg Volume 2.88M
Price 62.02
SMA20 3.90%
SMA50 7.98%
SMA200 16.88%
Trades
Volume 3,870,690
Change 1.76%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-16-24 Upgrade
Barclays
Underweight → Overweight
$53 → $69
Feb-06-24 Upgrade
BofA Securities
Underperform → Neutral
$47 → $62
Feb-01-24 Initiated
Citigroup
Neutral
$56
Sep-22-23 Initiated
HSBC Securities
Reduce
$49
Apr-20-23 Reiterated
Goldman
Neutral
$66 → $64
Apr-14-23 Resumed
BMO Capital Markets
Market Perform
$66
Feb-07-23 Downgrade
Goldman
Buy → Neutral
$91 → $66
Nov-28-22 Downgrade
Barclays
Equal Weight → Underweight
$89 → $58
Nov-09-22 Downgrade
BofA Securities
Neutral → Underperform
$73 → $61
Sep-13-22 Downgrade
Argus
Buy → Hold
Aug-09-22 Upgrade
Piper Sandler
Underweight → Neutral
$79
Jul-20-22 Downgrade
Cleveland Research
Buy → Neutral
May-03-22 Downgrade
Piper Sandler
Neutral → Underweight
$87 → $81
Mar-14-22 Downgrade
BMO Capital Markets
Outperform → Market Perform
$115 → $99
Feb-14-22 Downgrade
Barclays
Overweight → Equal Weight
$95 → $100
Feb-08-22 Reiterated
Stephens
Overweight
$110 → $115
Feb-08-22 Reiterated
JP Morgan
Neutral
$88 → $91
Feb-08-22 Reiterated
Credit Suisse
Neutral
$88 → $100
Feb-08-22 Reiterated
BofA Securities
Neutral
$90 → $100
Feb-08-22 Reiterated
BMO Capital Markets
Outperform
$90 → $115
Show Previous Ratings
May-03-24 03:37PM
02:33PM
11:38AM
10:35AM
08:32AM
04:15PM
Loading…
May-02-24 04:15PM
May-01-24 09:15AM
Apr-30-24 06:09AM
06:00AM
Apr-29-24 06:15PM
10:00AM
Apr-26-24 09:54AM
09:43AM
Apr-23-24 06:00PM
Apr-22-24 08:22PM
10:55AM
Loading…
Apr-18-24 10:55AM
Apr-17-24 06:00PM
02:50PM
(Investor's Business Daily)
Apr-16-24 12:10PM
Apr-15-24 06:15PM
Apr-12-24 10:35AM
Apr-10-24 04:22AM
Apr-09-24 06:00PM
08:00AM
(The Wall Street Journal)
Apr-06-24 08:25PM
Apr-05-24 06:15PM
Apr-03-24 11:06AM
Mar-30-24 07:19AM
Mar-29-24 09:40AM
Mar-27-24 06:15PM
04:05PM
Loading…
04:05PM
Mar-25-24 02:02PM
Mar-24-24 06:44PM
(Associated Press Finance)
10:04AM
Mar-22-24 06:31PM
(Associated Press Finance)
10:16AM
Mar-21-24 04:47PM
11:33AM
Mar-19-24 06:15PM
05:00AM
Mar-17-24 02:49PM
08:58AM
Mar-14-24 03:35PM
Mar-13-24 09:40AM
Mar-12-24 03:28PM
05:56AM
Mar-11-24 06:12PM
(Associated Press Finance)
05:09PM
05:04PM
03:18PM
Mar-10-24 10:26AM
09:26AM
Mar-08-24 06:08AM
Mar-06-24 06:30AM
Feb-29-24 10:59AM
Feb-28-24 10:21PM
Feb-26-24 09:40AM
08:18AM
Feb-15-24 01:45AM
Feb-14-24 12:04PM
04:00AM
04:00AM
Feb-13-24 10:11AM
Feb-09-24 09:00PM
(The Wall Street Journal)
Feb-08-24 04:05PM
04:00PM
09:40AM
Feb-07-24 05:55PM
Feb-06-24 08:24AM
12:35AM
(Thomson Reuters StreetEvents)
12:06AM
Feb-05-24 03:26PM
03:05PM
02:45PM
12:38PM
(The Wall Street Journal)
12:20PM
12:19PM
(The Wall Street Journal)
10:46AM
10:41AM
09:30AM
07:51AM
07:50AM
07:39AM
(Associated Press Finance)
07:34AM
07:30AM
Feb-04-24 02:01AM
Feb-01-24 10:04AM
Jan-31-24 09:15AM
Jan-29-24 06:15PM
11:01AM
03:30AM
Jan-25-24 09:00AM
Jan-24-24 05:47PM
11:43AM
09:54AM
09:32AM
05:29AM
Jan-22-24 06:15PM
Jan-19-24 09:40AM
Jan-17-24 12:00PM
Tyson Foods, Inc. engages in the processing of prepared food and other related products. It operates through the following segments: Beef, Pork, Chicken, and Prepared Foods. The Beef segment includes processing live fed cattle and fabricating dressed beef carcasses into primal and sub-primal meat cuts and case-ready products. The Pork segment focuses on live market hogs and fabricating pork carcasses. The Chicken segment is involved in raising and processing live chickens into fresh, frozen, and value-added chicken products, and sales from specialty products. The Prepared Foods segment manufactures and markets food products and offers logistic operations to move products through the supply chain. The company was founded by John W. Tyson in 1935 and is headquartered in Springdale, AR.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
White Noel W Director Feb 20 '24 Sale 53.75 9,000 483,748 31,115 Feb 22 12:54 PM MORRIS WES Group President Poultry Nov 17 '23 Sale 48.11 9,362 450,406 33,397 Nov 21 04:37 PM MORRIS WES Group President Poultry Nov 17 '23 Sale 48.13 1,000 48,128 0 Nov 21 04:37 PM TYSON JOHN H Chairman of the Board Nov 14 '23 Option Exercise 31.82 160,600 5,110,292 2,872,427 Nov 15 02:59 PM TYSON JOHN H Chairman of the Board Nov 14 '23 Sale 46.16 133,277 6,152,066 2,739,150 Nov 15 02:59 PM MCNAMARA KEVIN M Director May 12 '23 Buy 48.92 20,500 1,002,803 115,670 May 16 01:26 PM Soderstrom Johanna EVP & Chief People Officer May 12 '23 Buy 49.22 5,000 246,108 32,847 May 12 05:01 PM King Donnie President&CEO May 11 '23 Buy 48.35 10,350 500,422 195,478 May 12 05:01 PM MORRIS WES Group President Poultry May 10 '23 Buy 48.18 9,362 451,061 42,759 May 10 05:49 PM MORRIS WES Group President Poultry May 10 '23 Buy 48.18 1,000 48,180 500 May 10 05:49 PM Stewart Brady J. Group President Fresh Meats May 09 '23 Buy 48.89 2,040 99,736 57,478 May 10 05:49 PM
Index S&P 500
P/E 36.64
EPS (ttm) 2.33
Insider Own 1.58%
Shs Outstand 601.10M
Perf Week -1.37%
Market Cap 51.37B
Forward P/E 27.38
EPS next Y 3.11
Insider Trans -4.63%
Shs Float 593.08M
Perf Month -6.52%
Income 1.41B
PEG 3.91
EPS next Q 0.70
Inst Own 82.51%
Short Float 1.24%
Perf Quarter -0.98%
Sales 6.14B
P/S 8.36
EPS this Y 10.39%
Inst Trans -0.08%
Short Ratio 1.96
Perf Half Y 33.56%
Book/sh 11.82
P/B 7.21
EPS next Y 12.38%
ROA 15.38%
Short Interest 7.38M
Perf Year -3.23%
Cash/sh 2.82
P/C 30.20
EPS next 5Y 9.36%
ROE 21.59%
52W Range 60.57 - 96.12
Perf YTD 11.80%
Dividend Est. -
P/FCF 189.28
EPS past 5Y 15.35%
ROI 18.14%
52W High -11.31%
Beta 1.12
Dividend TTM -
Quick Ratio 2.67
Sales past 5Y 10.28%
Gross Margin 76.11%
52W Low 40.75%
ATR (14) 2.07
Dividend Ex-Date -
Current Ratio 3.75
EPS Y/Y TTM -3.43%
Oper. Margin 27.71%
RSI (14) 38.07
Volatility 2.30% 2.25%
Employees 19800
Debt/Eq 0.10
Sales Y/Y TTM 11.68%
Profit Margin 23.01%
Recom 2.12
Target Price 95.95
Option/Short Yes / Yes
LT Debt/Eq 0.09
EPS Q/Q 4.50%
Payout 0.00%
Rel Volume 0.61
Prev Close 85.06
Sales Surprise 1.80%
EPS Surprise 2.66%
Sales Q/Q 9.50%
Earnings Apr 25 AMC
Avg Volume 3.76M
Price 85.25
SMA20 -3.56%
SMA50 -5.25%
SMA200 8.60%
Trades
Volume 2,294,544
Change 0.22%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-07-24 Upgrade
BofA Securities
Neutral → Buy
Feb-02-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$94
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$80 → $77
Dec-11-23 Downgrade
Citigroup
Buy → Neutral
Nov-28-23 Downgrade
Wolfe Research
Peer Perform → Underperform
$57
Sep-26-23 Upgrade
Oppenheimer
Perform → Outperform
$90
Jul-19-23 Initiated
Robert W. Baird
Outperform
$107
May-30-23 Resumed
Morgan Stanley
Overweight
$102
Mar-29-23 Initiated
UBS
Neutral
$84
Mar-08-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$97 → $78
Feb-06-23 Downgrade
Raymond James
Outperform → Mkt Perform
Jan-31-23 Downgrade
Bernstein
Outperform → Underperform
$95 → $66
Jan-30-23 Downgrade
Piper Sandler
Overweight → Neutral
$95 → $80
Dec-06-22 Downgrade
Stifel
Buy → Hold
$95 → $75
Oct-28-22 Downgrade
Oppenheimer
Outperform → Perform
Oct-26-22 Initiated
Mizuho
Buy
$100
Oct-18-22 Initiated
Barclays
Overweight
$96
Oct-12-22 Initiated
Jefferies
Buy
$110
Jul-29-22 Downgrade
Canaccord Genuity
Buy → Hold
$115 → $106
Apr-13-22 Initiated
Truist
Buy
$145
Show Previous Ratings
May-01-24 05:27PM
09:40AM
09:35AM
Apr-30-24 05:03PM
10:20AM
02:22PM
Loading…
Apr-29-24 02:22PM
12:18PM
07:23AM
Apr-26-24 04:09PM
(Investor's Business Daily)
11:21AM
11:09AM
10:54AM
10:42AM
10:38AM
(Thomson Reuters StreetEvents)
10:29AM
09:53AM
Loading…
09:53AM
08:28AM
03:40AM
Apr-25-24 06:00PM
05:52PM
05:30PM
05:04PM
(Investor's Business Daily)
04:34PM
04:26PM
(Associated Press Finance)
04:15PM
Apr-23-24 06:14AM
Apr-22-24 09:16AM
Apr-19-24 01:08AM
Apr-18-24 10:01AM
07:10AM
11:01AM
Loading…
Apr-17-24 11:01AM
Apr-12-24 04:37AM
Apr-07-24 04:30PM
Mar-26-24 08:02AM
Mar-25-24 09:40AM
Mar-19-24 02:24PM
(Investor's Business Daily)
01:38PM
Mar-15-24 04:02PM
10:50AM
Mar-13-24 11:57AM
Mar-11-24 02:00PM
Mar-07-24 04:57PM
11:31AM
Mar-06-24 09:43AM
Feb-26-24 11:54AM
Feb-23-24 07:05AM
Feb-18-24 01:26PM
Feb-15-24 09:36AM
Feb-13-24 12:09AM
Feb-09-24 02:21AM
Feb-07-24 04:11PM
(Investor's Business Daily)
11:19AM
10:31AM
09:06AM
(Thomson Reuters StreetEvents)
05:54AM
Feb-06-24 07:55PM
06:00PM
05:25PM
04:54PM
04:44PM
(Investor's Business Daily)
04:40PM
(Associated Press Finance)
04:15PM
07:18AM
Feb-02-24 07:00AM
06:27AM
Feb-01-24 09:15AM
07:44AM
Jan-30-24 07:05AM
06:15AM
Jan-23-24 07:07AM
Jan-19-24 11:26AM
Jan-16-24 01:20AM
Jan-03-24 07:40AM
Jan-02-24 09:00AM
Dec-20-23 05:24AM
Dec-14-23 07:49PM
Dec-11-23 12:27PM
Dec-08-23 05:11AM
Dec-07-23 05:00PM
08:30AM
Nov-26-23 05:56AM
Nov-25-23 06:58AM
Nov-24-23 11:31AM
Nov-23-23 06:06AM
Oct-30-23 11:40AM
Oct-27-23 07:30AM
Oct-26-23 06:15PM
03:06PM
02:00PM
11:33AM
11:17AM
11:12AM
10:08AM
07:23AM
07:20AM
(Thomson Reuters StreetEvents)
Oct-25-23 06:00PM
06:00PM
05:40PM
04:32PM
(Associated Press Finance)
04:15PM
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MUSSALLEM MICHAEL A Director May 02 '24 Option Exercise 36.75 29,350 1,078,612 33,836 May 02 06:05 PM MUSSALLEM MICHAEL A Director May 02 '24 Sale 84.77 29,350 2,487,966 4,486 May 02 06:05 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 01 '24 Option Exercise 36.75 14,400 529,200 188,249 May 01 05:17 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 01 '24 Sale 84.21 14,400 1,212,687 173,849 May 01 05:17 PM Ullem Scott B. CVP, Chief Financial Officer Apr 30 '24 Option Exercise 36.75 7,250 266,438 26,324 Apr 30 04:56 PM Ullem Scott B. CVP, Chief Financial Officer Apr 30 '24 Sale 85.80 7,250 622,062 19,074 Apr 30 04:56 PM Lippis Daniel J. CVP, JAPAC Apr 09 '24 Option Exercise 36.75 857 31,495 18,345 Apr 09 05:33 PM Lippis Daniel J. CVP, JAPAC Apr 09 '24 Sale 92.34 857 79,135 17,488 Apr 09 05:33 PM Lemercier Jean-Luc M CVP, EMEACLA Apr 08 '24 Option Exercise 36.75 14,400 529,200 188,249 Apr 08 05:10 PM BOBO DONALD E JR CVP,Strategy/Corp Development Apr 08 '24 Option Exercise 36.75 12,500 459,375 52,268 Apr 08 05:10 PM Lemercier Jean-Luc M CVP, EMEACLA Apr 08 '24 Sale 92.32 14,400 1,329,472 173,849 Apr 08 05:10 PM BOBO DONALD E JR CVP,Strategy/Corp Development Apr 08 '24 Sale 92.33 12,500 1,154,142 39,768 Apr 08 05:10 PM MUSSALLEM MICHAEL A Director Apr 04 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Apr 04 06:26 PM MUSSALLEM MICHAEL A Director Apr 04 '24 Sale 92.42 29,350 2,712,418 4,486 Apr 04 06:26 PM Ullem Scott B. CVP, Chief Financial Officer Apr 01 '24 Option Exercise 36.75 7,255 266,621 26,329 Apr 01 06:55 PM Ullem Scott B. CVP, Chief Financial Officer Apr 01 '24 Sale 94.89 7,255 688,423 19,074 Apr 01 06:55 PM BOBO DONALD E JR CVP,Strategy/Corp Development Mar 13 '24 Option Exercise 36.75 14,500 532,875 54,003 Mar 13 05:44 PM BOBO DONALD E JR CVP,Strategy/Corp Development Mar 13 '24 Sale 91.01 14,500 1,319,696 39,503 Mar 13 05:44 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Mar 11 '24 Option Exercise 36.75 14,400 529,200 187,984 Mar 11 06:00 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Mar 11 '24 Sale 91.68 14,400 1,320,149 173,584 Mar 11 06:00 PM Lippis Daniel J. CVP, JAPAC Mar 07 '24 Option Exercise 36.75 1,715 63,026 18,928 Mar 07 06:22 PM Lippis Daniel J. CVP, JAPAC Mar 07 '24 Sale 90.98 1,715 156,031 17,213 Mar 07 06:22 PM MUSSALLEM MICHAEL A Director Mar 04 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Mar 04 07:16 PM MUSSALLEM MICHAEL A Director Mar 04 '24 Sale 86.67 29,350 2,543,737 4,486 Mar 04 07:16 PM Ullem Scott B. CVP, Chief Financial Officer Feb 29 '24 Option Exercise 36.75 7,255 266,621 26,329 Feb 29 05:12 PM Ullem Scott B. CVP, Chief Financial Officer Feb 29 '24 Sale 85.59 7,255 620,923 19,074 Feb 29 05:12 PM GALLAHUE KIERAN Director Feb 23 '24 Option Exercise 36.86 7,056 260,107 10,757 Feb 26 05:52 PM GALLAHUE KIERAN Director Feb 23 '24 Sale 87.61 3,058 267,911 67,219 Feb 26 05:52 PM Chopra Daveen CVP, TMTT Feb 21 '24 Option Exercise 59.26 7,000 414,797 30,950 Feb 21 05:52 PM Chopra Daveen CVP, TMTT Feb 21 '24 Sale 86.74 8,200 711,272 22,750 Feb 21 05:52 PM Szyman Catherine M. CVP, Critical Care Feb 15 '24 Option Exercise 36.75 27,000 992,250 61,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 15 '24 Sale 85.62 27,000 2,311,654 34,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 13 '24 Option Exercise 36.75 20,000 735,000 54,814 Feb 15 05:25 PM BOBO DONALD E JR CVP,Strategy/Corp Development Feb 13 '24 Option Exercise 36.75 11,000 404,250 50,503 Feb 13 04:51 PM Szyman Catherine M. CVP, Critical Care Feb 13 '24 Sale 86.46 20,000 1,729,200 34,814 Feb 15 05:25 PM BOBO DONALD E JR CVP,Strategy/Corp Development Feb 13 '24 Sale 85.83 11,000 944,155 39,503 Feb 13 04:51 PM SELLERS ROBERT W.A. SVP, Corporate Controller Feb 12 '24 Option Exercise 36.75 12,210 448,718 25,297 Feb 12 05:44 PM SELLERS ROBERT W.A. SVP, Corporate Controller Feb 12 '24 Sale 87.00 12,210 1,062,270 13,087 Feb 12 05:44 PM STONE HEISZ LESLIE Director Feb 08 '24 Option Exercise 36.86 7,056 260,107 34,036 Feb 08 06:08 PM STONE HEISZ LESLIE Director Feb 08 '24 Sale 86.45 7,056 609,991 26,980 Feb 08 06:08 PM MUSSALLEM MICHAEL A Director Feb 05 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Feb 05 06:37 PM MUSSALLEM MICHAEL A Director Feb 05 '24 Sale 87.49 29,350 2,567,754 4,486 Feb 05 06:37 PM Ullem Scott B. CVP, Chief Financial Officer Feb 01 '24 Option Exercise 36.75 7,255 266,621 26,503 Feb 01 05:52 PM Ullem Scott B. CVP, Chief Financial Officer Feb 01 '24 Sale 78.29 7,255 567,994 19,248 Feb 01 05:52 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jan 12 '24 Option Exercise 36.75 10,000 367,500 49,503 Jan 12 05:36 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jan 12 '24 Sale 75.67 10,000 756,700 39,503 Jan 12 05:36 PM MUSSALLEM MICHAEL A Director Jan 05 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Jan 05 07:19 PM MUSSALLEM MICHAEL A Director Jan 05 '24 Sale 72.98 29,350 2,142,089 4,486 Jan 05 07:19 PM Ullem Scott B. CVP, Chief Financial Officer Dec 29 '23 Option Exercise 36.75 14,510 533,242 33,758 Dec 29 04:25 PM Ullem Scott B. CVP, Chief Financial Officer Dec 29 '23 Sale 76.55 14,510 1,110,794 19,248 Dec 29 04:25 PM Chopra Daveen CVP, TMTT Dec 15 '23 Option Exercise 59.26 7,000 414,797 30,950 Dec 15 05:22 PM Chopra Daveen CVP, TMTT Dec 15 '23 Sale 78.25 7,000 547,724 23,950 Dec 15 05:22 PM MUSSALLEM MICHAEL A Director Dec 13 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Dec 13 07:04 PM Wood Larry L Global President TAVR & Surg Dec 13 '23 Option Exercise 45.28 8,658 392,006 222,452 Dec 13 07:04 PM BOBO DONALD E JR CVP,Strategy/Corp Development Dec 13 '23 Option Exercise 36.75 8,000 294,000 47,503 Dec 13 07:04 PM MUSSALLEM MICHAEL A Director Dec 13 '23 Sale 74.62 29,350 2,190,043 4,486 Dec 13 07:04 PM Wood Larry L Global President TAVR & Surg Dec 13 '23 Sale 71.86 8,658 622,164 213,794 Dec 13 07:04 PM BOBO DONALD E JR CVP,Strategy/Corp Development Dec 13 '23 Sale 71.86 8,000 574,880 39,503 Dec 13 07:04 PM Chopra Daveen CVP, TMTT Dec 06 '23 Option Exercise 59.26 3,500 207,398 27,450 Dec 06 05:01 PM Chopra Daveen CVP, TMTT Dec 06 '23 Sale 70.00 3,500 245,006 23,950 Dec 06 05:01 PM Wood Larry L Global President TAVR & Surg Nov 13 '23 Option Exercise 45.28 8,660 392,096 222,454 Nov 13 05:21 PM BOBO DONALD E JR CVP,Strategy/Corp Development Nov 13 '23 Option Exercise 36.75 6,000 220,500 45,503 Nov 13 05:21 PM Wood Larry L Global President TAVR & Surg Nov 13 '23 Sale 65.30 8,660 565,460 213,794 Nov 13 05:21 PM BOBO DONALD E JR CVP,Strategy/Corp Development Nov 13 '23 Sale 65.30 6,000 391,780 39,503 Nov 13 05:21 PM MUSSALLEM MICHAEL A Director Nov 03 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Nov 06 06:33 PM MUSSALLEM MICHAEL A Director Nov 03 '23 Sale 67.18 29,350 1,971,733 4,486 Nov 06 06:33 PM Ullem Scott B. CVP, Chief Financial Officer Oct 31 '23 Option Exercise 36.75 7,255 266,621 26,503 Oct 31 05:22 PM Ullem Scott B. CVP, Chief Financial Officer Oct 31 '23 Sale 62.66 7,255 454,569 19,248 Oct 31 05:22 PM Wood Larry L Global President TAVR & Surg Oct 13 '23 Option Exercise 45.28 8,660 392,096 222,454 Oct 13 05:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Oct 13 '23 Option Exercise 36.75 5,000 183,750 44,503 Oct 13 05:01 PM Wood Larry L Global President TAVR & Surg Oct 13 '23 Sale 70.00 8,660 606,198 213,794 Oct 13 05:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Oct 13 '23 Sale 69.98 5,000 349,909 39,503 Oct 13 05:01 PM Szyman Catherine M. CVP, Critical Care Oct 10 '23 Option Exercise 36.75 5,000 183,750 39,814 Oct 10 06:23 PM Szyman Catherine M. CVP, Critical Care Oct 10 '23 Sale 72.68 5,000 363,400 34,814 Oct 10 06:23 PM Chopra Daveen CVP, TMTT Oct 03 '23 Option Exercise 59.26 8,500 503,682 32,450 Oct 03 04:58 PM Chopra Daveen CVP, TMTT Oct 03 '23 Sale 70.00 8,500 595,000 23,950 Oct 03 04:58 PM MUSSALLEM MICHAEL A Director Oct 02 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Oct 02 06:51 PM MUSSALLEM MICHAEL A Director Oct 02 '23 Sale 68.84 29,350 2,020,454 4,486 Oct 02 06:51 PM Ullem Scott B. CVP, Chief Financial Officer Sep 29 '23 Option Exercise 36.75 7,255 266,621 26,503 Sep 29 04:49 PM Ullem Scott B. CVP, Chief Financial Officer Sep 29 '23 Sale 69.54 7,255 504,527 19,248 Sep 29 04:49 PM Wood Larry L Global President TAVR & Surg Sep 14 '23 Option Exercise 45.28 8,660 392,096 222,454 Sep 14 08:00 PM BOBO DONALD E JR CVP,Strategy/Corp Development Sep 14 '23 Option Exercise 36.75 4,500 165,375 44,003 Sep 14 08:00 PM Wood Larry L Global President TAVR & Surg Sep 14 '23 Sale 73.63 8,660 637,615 213,794 Sep 14 08:00 PM BOBO DONALD E JR CVP,Strategy/Corp Development Sep 14 '23 Sale 73.71 4,500 331,695 39,503 Sep 14 08:00 PM Szyman Catherine M. CVP, Critical Care Sep 08 '23 Option Exercise 36.75 5,000 183,750 39,814 Sep 08 05:29 PM Szyman Catherine M. CVP, Critical Care Sep 08 '23 Sale 76.00 5,000 380,000 34,814 Sep 08 05:29 PM Chopra Daveen CVP, TMTT Sep 06 '23 Option Exercise 59.26 8,500 503,682 32,450 Sep 06 05:09 PM Chopra Daveen CVP, TMTT Sep 06 '23 Sale 76.07 8,500 646,609 23,950 Sep 06 05:09 PM MUSSALLEM MICHAEL A Director Sep 05 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Sep 05 07:08 PM MUSSALLEM MICHAEL A Director Sep 05 '23 Sale 75.86 29,350 2,226,491 4,486 Sep 05 07:08 PM Ullem Scott B. CVP, Chief Financial Officer Aug 31 '23 Option Exercise 36.75 7,255 266,621 26,503 Aug 31 05:34 PM Ullem Scott B. CVP, Chief Financial Officer Aug 31 '23 Sale 77.79 7,255 564,366 19,248 Aug 31 05:34 PM Chopra Daveen CVP, TMTT Aug 29 '23 Sale 76.69 1,500 115,040 23,950 Aug 29 05:31 PM Wood Larry L Global President TAVR & Surg Aug 14 '23 Option Exercise 45.28 6,421 290,722 220,215 Aug 14 06:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Aug 14 '23 Option Exercise 36.75 4,500 165,375 44,003 Aug 14 06:02 PM Wood Larry L Global President TAVR & Surg Aug 14 '23 Sale 79.30 6,421 509,185 213,794 Aug 14 06:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Aug 14 '23 Sale 79.30 4,500 356,850 39,503 Aug 14 06:02 PM STONE HEISZ LESLIE Director Aug 10 '23 Sale 78.87 3,303 260,509 26,980 Aug 10 05:48 PM Szyman Catherine M. CVP, Critical Care Aug 09 '23 Option Exercise 36.75 5,000 183,750 39,814 Aug 09 05:44 PM Szyman Catherine M. CVP, Critical Care Aug 09 '23 Sale 78.64 5,000 393,185 34,814 Aug 09 05:44 PM
Index S&P 500
P/E 41.22
EPS (ttm) 3.57
Insider Own 0.12%
Shs Outstand 312.29M
Perf Week 2.92%
Market Cap 45.91B
Forward P/E 117.46
EPS next Y 1.25
Insider Trans -0.90%
Shs Float 311.91M
Perf Month 5.09%
Income 1.12B
PEG -
EPS next Q 0.24
Inst Own 101.40%
Short Float 3.20%
Perf Quarter 1.74%
Sales 5.47B
P/S 8.39
EPS this Y -50.00%
Inst Trans 0.90%
Short Ratio 4.97
Perf Half Y 16.23%
Book/sh 58.54
P/B 2.51
EPS next Y -16.57%
ROA 2.75%
Short Interest 9.97M
Perf Year 55.08%
Cash/sh 3.82
P/C 38.45
EPS next 5Y -
ROE 6.41%
52W Range 86.33 - 154.18
Perf YTD 9.23%
Dividend Est. 4.93 (3.35%)
P/FCF -
EPS past 5Y 19.90%
ROI 3.08%
52W High -4.66%
Beta 0.58
Dividend TTM 4.88 (3.32%)
Quick Ratio -
Sales past 5Y 12.62%
Gross Margin 21.75%
52W Low 70.28%
ATR (14) 3.99
Dividend Ex-Date Dec 14, 2023
Current Ratio -
EPS Y/Y TTM 218.59%
Oper. Margin 13.15%
RSI (14) 61.51
Volatility 2.95% 2.36%
Employees 3664
Debt/Eq 0.97
Sales Y/Y TTM 11.55%
Profit Margin 20.49%
Recom 2.28
Target Price 147.10
Option/Short Yes / Yes
LT Debt/Eq 0.92
EPS Q/Q 309.31%
Payout 162.84%
Rel Volume 1.64
Prev Close 140.15
Sales Surprise -2.32%
EPS Surprise 182.86%
Sales Q/Q -0.57%
Earnings May 02 AMC
Avg Volume 2.00M
Price 147.00
SMA20 4.93%
SMA50 3.54%
SMA200 10.61%
Trades
Volume 3,293,862
Change 4.89%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-09-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$135 → $155
Feb-16-24 Downgrade
Scotiabank
Sector Outperform → Sector Perform
$157
Jan-22-24 Upgrade
Scotiabank
Sector Perform → Sector Outperform
$132 → $157
Dec-06-23 Initiated
KeyBanc Capital Markets
Sector Weight
Dec-01-23 Initiated
HSBC Securities
Reduce
$112
Oct-13-23 Initiated
Scotiabank
Sector Perform
$132
Aug-25-23 Downgrade
Deutsche Bank
Buy → Hold
$112 → $131
Jul-28-23 Upgrade
Exane BNP Paribas
Neutral → Outperform
$138
Mar-27-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
$121 → $100
Jan-04-23 Downgrade
Credit Suisse
Neutral → Underperform
$91 → $81
Dec-14-22 Initiated
Exane BNP Paribas
Neutral
$128
Dec-14-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$120 → $115
Sep-23-22 Downgrade
Barclays
Equal Weight → Underweight
$126 → $91
Jun-30-22 Upgrade
Jefferies
Hold → Buy
$151 → $160
Jun-15-22 Upgrade
Deutsche Bank
Hold → Buy
$150 → $144
Feb-18-22 Reiterated
Wells Fargo
Overweight
$180 → $155
Feb-18-22 Reiterated
Stifel
Buy
$195 → $170
Feb-18-22 Reiterated
Credit Suisse
Neutral
$150 → $146
Feb-18-22 Reiterated
Cowen
Market Perform
$162 → $149
Feb-18-22 Reiterated
Barclays
Equal Weight
$158 → $154
Show Previous Ratings
Today 10:05AM
May-03-24 02:17PM
10:44AM
08:34AM
07:47AM
(Thomson Reuters StreetEvents)
06:11AM
Loading…
06:11AM
06:09AM
06:09AM
06:08AM
06:08AM
03:16AM
May-02-24 08:57PM
08:45PM
06:00PM
05:15PM
04:51PM
Loading…
04:51PM
04:12PM
(Associated Press Finance)
04:05PM
04:05PM
01:40PM
Apr-30-24 04:08PM
Apr-29-24 01:37PM
09:16AM
Apr-24-24 04:30PM
Apr-22-24 02:55PM
(Investor's Business Daily)
08:58AM
Apr-18-24 05:42PM
Apr-11-24 09:30AM
Apr-08-24 08:14AM
Apr-03-24 01:40PM
08:30AM
Loading…
08:30AM
Apr-02-24 08:37AM
Apr-01-24 04:10PM
Mar-25-24 03:20AM
Mar-24-24 10:01AM
08:02AM
Mar-15-24 04:30PM
Mar-14-24 07:14AM
Mar-13-24 07:04AM
05:40AM
Mar-12-24 07:49AM
Mar-07-24 04:15AM
Mar-06-24 08:42AM
Mar-05-24 10:00PM
11:12AM
Mar-04-24 06:00AM
05:05AM
Mar-02-24 05:44AM
Feb-28-24 04:05PM
Feb-24-24 12:04AM
Feb-22-24 09:01AM
Feb-21-24 01:57PM
Feb-16-24 11:28AM
(Morningstar Research) -8.34%
11:22AM
10:50AM
09:31AM
(Thomson Reuters StreetEvents)
Feb-15-24 10:00PM
06:31PM
06:00PM
05:15PM
04:33PM
04:26PM
(Associated Press Finance)
04:05PM
Feb-14-24 09:41AM
Feb-12-24 09:16AM
Feb-01-24 06:20AM
Jan-31-24 07:00PM
Jan-25-24 04:15PM
11:30AM
Jan-24-24 06:56PM
Jan-23-24 01:22PM
05:12AM
Jan-22-24 08:00AM
Jan-19-24 10:25AM
Jan-18-24 10:38AM
Jan-17-24 12:30PM
07:31AM
Jan-12-24 04:15AM
Jan-06-24 06:10AM
Jan-05-24 06:30AM
Jan-03-24 04:10PM
Jan-02-24 06:37AM
Dec-30-23 05:00PM
Dec-20-23 05:54PM
10:22AM
Dec-18-23 05:39AM
Dec-13-23 05:46PM
05:12AM
Dec-11-23 06:37PM
06:45AM
Dec-08-23 07:48AM
Dec-07-23 05:53PM
05:40PM
04:35PM
04:05PM
(The Wall Street Journal)
Dec-05-23 01:15PM
09:00AM
Nov-28-23 04:38PM
Nov-19-23 08:00AM
Nov-17-23 10:11AM
Digital Realty Trust, Inc. operates as a real estate investment trust, which engages in the provision of data center, colocation and interconnection solutions. It serves the following industries: artificial intelligence (AI), networks, cloud, digital media, mobile, financial services, healthcare, and gaming. The company was founded on March 9, 2004, and is headquartered in Austin, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MANDEVILLE JEAN F H P Director Mar 12 '24 Sale 145.50 3,400 494,700 8,413 Mar 13 07:27 PM Fiedelman Cindy CHIEF HUMAN RESOURCES OFFICER Jul 28 '23 Option Exercise 0.00 2,770 0 2,770 Aug 01 07:23 PM Fiedelman Cindy CHIEF HUMAN RESOURCES OFFICER Jul 28 '23 Sale 125.00 2,770 346,250 0 Aug 01 07:23 PM Olson Peter C. CHIEF ACCOUNTING OFFICER Jun 12 '23 Sale 105.67 700 73,969 7,134 Jun 14 05:57 PM MANDEVILLE JEAN F H P Director May 15 '23 Sale 97.47 1,500 146,205 10,176 May 17 05:19 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite